Sign inJoin waitlistJoin the waitlist

LP

Lauren Pinter-Brown

Professor — Division of Hematology and Oncology, Medicine · University of California

Credentials: · · · · ·

History

University of California
Present
University of California
Present

Hematology and Medical Oncology
1983–1986
Internal Medicine
1980–1983
David Geffen Sch of Med at UCLA
1976–1980

Research

Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy
Journal of Clinical Oncology · 2012 · 564 citations
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
The Lancet Oncology · 2018 · 552 citations
Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States…
Journal of Clinical Oncology · 2011 · 548 citations

SH
Steven Horwitz
23 papers
Francine Foss
17 papers
AS
Andrei Shustov
15 papers
Barbara Pro
14 papers
MD
Madeleine Duvic
13 papers
YK
Youn-Hee Kim
13 papers
Mary Lechowicz
9 papers
Ranjana Advani
9 papers
Sonali Smith
9 papers
KC
Kenneth Carson
8 papers
Eric Hsi
7 papers
Steven Rosen
7 papers

Clinical trials

GCS-100LE in Combination With Etoposide and Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Principal investigator · Withdrawn · Phase 1, Phase 2
La Jolla Pharmaceutical Company
2008–2009
Denileukin Diftitox in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Principal investigator · Completed · Phase 2
Jonsson Comprehensive Cancer Center
2004–2008
Bortezomib in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma
Principal investigator · Completed · Phase 2
Jonsson Comprehensive Cancer Center
2004–2010